keyword
https://read.qxmd.com/read/38701311/nongestational-ovarian-choriocarcinoma-with-bilateral-teratoma-a-rare-case-report-and-literature-review
#21
REVIEW
Xue Ao, Sha Hu, Shiqiao Tan, Wei Xiong
INTRODUCTION: Trophoblastic neoplasms are often associated with pregnancy, and nongestational trophoblastic neoplasms are extremely rare. Nongestational ovarian choriocarcinoma (NGCO) is a highly aggressive germ cell-derived tumor frequently presenting with early hematogenous metastasis. PATIENT CONCERNS: Herein, we report a case of a 28-year-old unmarried woman with regular menstruation who experienced vaginal bleeding 1 week after her last menstrual cycle. Doppler ultrasound revealed bilateral adnexal masses and elevated serum human chorionic gonadotropin (hCG) levels...
May 3, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38701117/otub2-silencing-promotes-ovarian-cancer-via-mitochondrial-metabolic-reprogramming-and-can-be-synthetically-targeted-by-ca9-inhibition
#22
JOURNAL ARTICLE
Yabing Nan, Xiaowei Wu, Qingyu Luo, Wan Chang, Pengfei Zhao, Lingqiang Zhang, Zhihua Liu
Ovarian cancer is an aggressive gynecological tumor characterized by a high relapse rate and chemoresistance. Ovarian cancer exhibits the cancer hallmark of elevated glycolysis, yet effective strategies targeting cancer cell metabolic reprogramming to overcome therapeutic resistance in ovarian cancer remain elusive. Here, we revealed that epigenetic silencing of Otubain 2 ( OTUB2 ) is a driving force for mitochondrial metabolic reprogramming in ovarian cancer, which promotes tumorigenesis and chemoresistance...
May 7, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38699463/bilateral-singapore-fasciocutaneous-flap-after-anterior-vulvectomy-and-distal-urethrectomy-for-localized-recurrent-vulvar-carcinoma
#23
JOURNAL ARTICLE
Madison Crum, Caela Miller, Christopher Micallef, Richard Delaney, Erica Hope
INTRODUCTION: Vulvar cancer has an overall low incidence, accounting for approximately 3-5% of all gynecological malignancies.Case: We present a case of locally recurrent Stage IIIA squamous cell carcinoma of the vulva in a 51-year-old healthy African American female. She was initially treated with primary chemoradiation with cisplatin sensitization and boost to primary tumor up to 70 Gray. Post-treatment biopsies revealed complete pathologic response. She later presented with local recurrence to the primary site of the clitoris and vulva, with no evidence of metastasis on imaging, with progressive disease despite treatment with immunotherapy...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38698874/unsuccessful-laparoscopic-resection-of-a-large-pelvic-solitary-fibrous-tumor-a-case-report
#24
Xuping Shao, Haomeng Zhang, Yanqiu Wang, Changzhong Li, Jipeng Wan, Yonghui Zou
We present a rare case of a female pelvic solitary fibrous tumor unsuccessfully resected using single-port laparoscopy, requiring conversion to laparotomy. Although the resection was successful, the surgical approach could have been improved. For large tumors, minimally invasive results are possible with flexible choices of equipment and incision position.
May 2024: Clinical Case Reports
https://read.qxmd.com/read/38698835/supplementation-with-nad-and-its-precursors-a-rescue-of-female-reproductive-diseases
#25
REVIEW
Lan Li, Xin Zhou, Wene Liu, Zhen Chen, Xiaoqin Xiao, Guiming Deng
Nicotinamide adenine dinucleotide (NAD+ ) is an essential coenzyme involved in many pathophysiological processes. Supplementation with NAD+ and its precursors has been demonstrated as an emerging therapeutic strategy for the diseases. NAD+ also plays an important role in the reproductive system. Here, we summarize the function of NAD+ in various reproductive diseases and review the application of NAD+ and its precursors in the preservation of reproductive capacity and the prevention of embryonic malformations...
July 2024: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/38698330/sesamolin-serves-as-an-myh14-inhibitor-to-sensitize-endometrial-cancer-to-chemotherapy-and-endocrine-therapy-via-suppressing-myh9-gsk3%C3%AE-%C3%AE-catenin-signaling
#26
JOURNAL ARTICLE
Yibin Lin, Xiao Chen, Linping Lin, Benhua Xu, Xiaofeng Zhu, Xian Lin
BACKGROUND: Endometrial cancer (EC) is one of the most common gynecological cancers. Herein, we aimed to define the role of specific myosin family members in EC because this protein family is involved in the progression of various cancers. METHODS: Bioinformatics analyses were performed to reveal EC patients' prognosis-associated genes in patients with EC. Furthermore, colony formation, immunofluorescence, cell counting kit 8, wound healing, and transwell assays as well as coimmunoprecipitation, cycloheximide chase, luciferase reporter, and cellular thermal shift assays were performed to functionally and mechanistically analyze human EC samples, cell lines, and a mouse model, respectively...
May 2, 2024: Cellular & Molecular Biology Letters
https://read.qxmd.com/read/38697755/management-of-endometrial-cancer-in-latin-america-raising-the-standard-of-care-and-optimizing-outcomes
#27
REVIEW
Albano Blanco, Angélica Nogueira-Rodrigues, Filomena Marino Carvalho, Gonzalo Giornelli, Mansoor Raza Mirza
Molecular characterization of endometrial cancer is allowing for increased understanding of the natural history of tumors and paving a more solid pathway for novel therapies. It is becoming increasingly apparent that molecular classification is superior to histological classification in terms of reproducibility and prognostic discrimination. In particular, the Proactive Molecular Risk Classifier for Endometrial Cancer allows classification of endometrial cancer into groups very close to those determined by the Cancer Genome Atlas Research Network-that is, DNA polymerase epsilon-mutated, mismatch repair-deficient, p53 abnormal, and non-specific molecular profile tumors...
May 2, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38697202/quality-of-care-measurement-for-patients-with-ovarian-cancer-in-japan
#28
JOURNAL ARTICLE
Tamaki Kakuwa, Tomone Watanabe, Mariko Niino, Akira Kawata, Toyomi Satoh, Noriomi Matsumura, Yoshihito Yokoyama, Kei Kawana, Yasuyuki Hirashima, Satoru Kyo, Masanori Yasuda, Kenichi Harano, Hiroko Machida, Hideki Tokunaga, Masanori Kaneuchi, Tsutomu Tabata, Yoichi Kobayashi, Satoru Nagase, Hidetaka Katabuchi, Mikio Mikami, Yoko Yamamoto, Ryoko Rikitake, Yuichi Ichinose, Takahiro Higashi
AIM: Quality of care is important to reduce disease progression, and improve both survival and quality of life. The Japan Society of Gynecologic Oncology has published treatment guidelines to promote standardized high-quality care for ovarian cancer in Japan. We developed quality indicators based on the guideline recommendations and used them on large datasets of health service use to examine the quality of ovarian cancer care. METHODS: A panel of experts developed the indicators using a modified Delphi method...
May 2, 2024: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/38697037/evaluating-the-risk-of-malignancies-of-the-diagnostic-categories-proposed-by-the-world-health-organization-system-for-reporting-lung-cytopathology-a-two-year-single-institutional-experience
#29
JOURNAL ARTICLE
Wei-An Lai, Chien-Chin Chen
Introduction The WHO System of Reporting Lung Cytopathology proposed a 5-tiered system in 2023. We report the risk of malignancies (ROMs) of bronchial washing/lavage and percutaneous fine needle aspiration (FNA) specimens. We also evaluated the change of ROMs when image correlation is required. Methods Lung cytology cases in 2021 and 2022 with histologic follow-up were included. CT reports were reviewed to identify cases with a solid nodule/tumor but benign cytological findings. These were reassigned from the "Benign" to "Non-diagnostic" category, and the ROMs were re-estimated...
May 2, 2024: Acta Cytologica
https://read.qxmd.com/read/38696842/antitumor-immunity-and-prognosis-value-elicited-by-fat3-and-lrp1b-co-mutation-in-endometrial-cancer
#30
JOURNAL ARTICLE
Zhansheng Jiang, Mingyu Zhu, Lu Zhang, Haiyan Cui, Richeng Jiang, Yanfang Yang
OBJECTIVE: FAT3 and LRP1B are two tumor suppressor genes with high mutation frequency in multiple cancer types, we sought to investigate the prognostic and immunological significance of these two genes in EC. METHODS: Based on a cohort of 502 EC samples, we conducted a comprehensive analysis of its multidimensional data types including genomic, transcriptomic, and clinical information, the potential impact of FAT3 and LRP1B co-mutation on antitumor immune response and prognosis were systematically discussed...
April 30, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38695128/asymptomatic-endometrial-cancer-with-lynch-syndrome-in-a-woman-with-primary-infertility-a-case-report-and-literature-review
#31
REVIEW
Nancy Noah, Misha Gilani, Ranitha Kumar
Lynch syndrome, also called hereditary non-polyposis colorectal cancer, is an autosomal dominant disorder characterized by germline pathogenic mutations in DNA mismatch repair genes-resulting in increased susceptibility to colorectal, endometrial, and other tumors. This case report presents an incidental finding of endometrial cancer with Lynch syndrome during investigation for primary infertility. A 34-year-old woman presented to the fertility clinic with unexplained primary infertility. Investigations showed possible endometrial polyp, 13 × 11 mm in size...
May 2, 2024: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/38694875/disulfidptosis-related-signature-elucidates-the-prognostic-immunologic-and-therapeutic-characteristics-in-ovarian-cancer
#32
JOURNAL ARTICLE
Yunyan Cong, Guangyao Cai, Chengcheng Ding, Han Zhang, Jieping Chen, Shiwei Luo, Jihong Liu
INTRODUCTION: Ovarian cancer (OC) is the deadliest malignancy in gynecology, but the mechanism of its initiation and progression is poorly elucidated. Disulfidptosis is a novel discovered type of regulatory cell death. This study aimed to develop a novel disulfidptosis-related prognostic signature (DRPS) for OC and explore the effects and potential treatment by disulfidptosis-related risk stratification. METHODS: The disulfidptosis-related genes were first analyzed in bulk RNA-Seq and a prognostic nomogram was developed and validated by LASSO algorithm and multivariate cox regression...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38694662/heterogeneity-of-cervical-cancer-associated-tertiary-lymphoid-structures-tlss-and-their-specific-interrelation-with-clinicopathological-parameters
#33
JOURNAL ARTICLE
Lavinia Bălan, Anca Maria Cimpean, Cristina Secosan, Virgiliu-Bogdan Sorop, Catalin Balan, Mihaela Moldovan, Eugen Melnic, Ligia Balulescu, Simona Brasoveanu, Laurentiu Pirtea
OBJECTIVE: The study investigates morphological variants of tertiary lymphoid structures (TLSs) in relation to cervical cancer development, from intraepithelial neoplastic lesions to invasive carcinomas with locoregional lymph node metastases. MATERIALS AND METHODS: This retrospective analysis comprised 100 cervical cancer cases who had had total hysterectomy with lymphadenectomy in the Obstetrics and Gynecology Clinic of the Municipal Emergency Clinical Hospital of Timisoara, Romania, from 2020 to 2023...
April 2024: Curēus
https://read.qxmd.com/read/38693541/an-isolated-vaginal-metastasis-from-rectal-cancer-a-case-report
#34
JOURNAL ARTICLE
Saida Sakhri, Ines Zemni, Mohamed Ali Ayadi, Ayoub Ghazouani, Nadia Boujelbene, Tarek Ben Dhiab
INTRODUCTION: Vaginal metastasis from colorectal cancer is a rare occurrence, typically associated with other metastatic lesions. Isolated metastasis is exceedingly uncommon, with only a few cases documented in the literature. Vaginal involvement in colorectal cancer primarily results from direct contiguous spread from the primary tumor. CASE PRESENTATION: We present the case of a 70-year-old African woman diagnosed with adenocarcinoma of the middle rectum. She underwent chemotherapy, radiotherapy, and subsequent anterior resection...
May 2, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38690293/current-strategies-for-early-epithelial-ovarian-cancer-detection-using-mirna-as-a-potential-tool
#35
REVIEW
Mridula Bhadra, Manisha Sachan, Seema Nara
Ovarian cancer is one of the most aggressive and significant malignant tumor forms in the female reproductive system. It is the leading cause of death among gynecological cancers owing to its metastasis. Since its preliminary disease symptoms are lacking, it is imperative to develop early diagnostic biomarkers to aid in treatment optimization and personalization. In this vein, microRNAs, which are short sequence non-coding molecules, displayed great potential as highly specific and sensitive biomarker. miRNAs have been extensively advocated and proven to serve an instrumental part in the clinical management of cancer, especially ovarian cancer, by promoting the cancer cell progression, invasion, delayed apoptosis, epithelial-mesenchymal transition, metastasis of cancer cells, chemosensitivity and resistance and disease therapy...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38689519/machine-learning-models-for-prediction-of-postoperative-venous-thromboembolism-in-gynecological-malignant-tumor-patients
#36
JOURNAL ARTICLE
Bijuan Lin, Fang Chen, Meiying Wu, Chaojing Li, Lanzhi Lin
AIM: To identify risk factors that associated with the occurrence of venous thromboembolism (VTE) within 30 days after hysterectomy among gynecological malignant tumor patients, and to explore the value of machine learning (ML) models in VTE occurrence prediction. METHODS: A total of 1087 patients between January 2019 and January 2022 with gynecological malignant tumors were included in this single-center retrospective study and were randomly divided into the training dataset (n = 870) and the test dataset (n = 217)...
April 30, 2024: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/38688602/arid1-and-brg1-expression-in-endometrial-cancer
#37
JOURNAL ARTICLE
Emmanuel N Kontomanolis, Panagiotis Symeonidis, Konstantinos Nikolettos, Paraskevas Perros, Achim Rody, Panagiotis Tsikouras, Nikolaos Nikolettos, Alexandra Giatromanolaki
BACKGROUND/AIM: Endometrial cancer (EC) is the predominant malignancy among gynecologic cancers and ranks fourth among all types of cancer. Recently, researchers have focused on the development of new prognostic biomarkers. Subunits of the SWI/SNF protein complex, like the ARID1 and BRG1, have been associated with the development of endometrial cancer. The present study aimed to evaluate the expression patterns of ARID1A and BRG1 in a collection of endometrioid adenocarcinomas of the uterus using immunohistochemistry...
2024: In Vivo
https://read.qxmd.com/read/38687597/clinical-and-genomic-landscape-of-ras-mutations-in-gynecologic-cancers
#38
JOURNAL ARTICLE
Ji Son, Yingao Zhang, Heather Lin, Oriol Mirallas, Pablo Alvarez Ballesteros, Mirella Nardo, Natalie Clark, R Tyler Hillman, Erick Campbell, Vijaykumar Holla, Amber M Johnson, Amadeo B Biter, Ying Yuan, Lauren P Cobb, David M Gershenson, Amir A Jazaeri, Karen H Lu, Pamela T Soliman, Shannon N Westin, Elizabeth D Euscher, Barrett C Lawson, Richard K Yang, Funda Meric-Bernstam, David S Hong
BACKGROUND: We aimed to describe RAS mutations in gynecologic cancers as they relate to clinicopathologic and genomic features, survival, and therapeutic implications. METHODS: Gynecologic cancers with available somatic molecular profiling data at our institution between February 2010 and August 2022 were included and grouped by RAS mutation status. Overall survival was estimated by Kaplan-Meier method, and multivariable analysis was performed using Cox proportional-hazards model...
April 30, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38681981/uterine-adenosarcoma-presenting-as-uterine-inversion-a-case-study
#39
Caitlin Witt, Chelsey Vranes, Leslie H Clark
•Non-puerperal uterine inversion can be associated with uterine sarcomas.•Adenosarcoma is a tumor composed of benign epithelium and malignant stroma.•If malignancy is suspected or confirmed treatment of uterine inversion with hysterectomy is advised.
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38678288/low-grade-undifferentiated-sarcoma-with-meis1-ncoa2-rearrangement-primary-to-the-lung-a-case-report
#40
JOURNAL ARTICLE
Zachary Coty-Fattal, Bianca Carter, Michael J Volek, Farres Obeidin
BACKGROUND: MEIS1::NCOA2 is a rare fusion gene that has been recently described in a subset of spindle cell rhabdomyosarcomas and multiple low-grade undifferentiated spindle cell sarcomas predominantly arising in the genitourinary and gynecologic tracts with no specific line of differentiation. We present the first documented case of this neoplasm arising as a lung primary tumor. CASE PRESENTATION: A 74-year-old woman with a 40-year smoking history presented with a 2...
April 27, 2024: Diagnostic Pathology
keyword
keyword
54797
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.